Meat intake and cancer risk: prospective analyses in UK Biobank

Background Red and processed meat have been consistently associated with colorectal cancer risk, but evidence for other cancer sites and for poultry intake is limited. We therefore examined associations between total, red and processed meat and poultry intake and incidence for 20 common cancers. Me...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Knuppel, A, Papier, K, Fensom, G, Appleby, P, Schmidt, JA, Tong, Y, Wrightson, R, Key, T, Perez-Cornago, A
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: Oxford University Press 2020
_version_ 1826294090802659328
author Knuppel, A
Papier, K
Fensom, G
Appleby, P
Schmidt, JA
Tong, Y
Wrightson, R
Key, T
Perez-Cornago, A
author_facet Knuppel, A
Papier, K
Fensom, G
Appleby, P
Schmidt, JA
Tong, Y
Wrightson, R
Key, T
Perez-Cornago, A
author_sort Knuppel, A
collection OXFORD
description Background Red and processed meat have been consistently associated with colorectal cancer risk, but evidence for other cancer sites and for poultry intake is limited. We therefore examined associations between total, red and processed meat and poultry intake and incidence for 20 common cancers. Methods We analyzed data from 474 996 participants (54% women) in UK Biobank. Participants were aged 37–73 years and cancer-free at baseline (2006–10). Multivariable-adjusted Cox proportional hazards models were used to determine associations between baseline meat intake and cancer incidence. Trends in risk across the baseline categories were calculated, assigning re-measured intakes from a subsample. Results During a mean follow-up of 6.9 years, 28 955 participants were diagnosed with malignant cancer. After correction for multiple testing, red and processed meat combined, and processed meat, were each positively associated with colorectal cancer risk [hazard ratio (HR) per 70 g/day higher intake of red and processed meat 1.32, 95% confidence interval 1.14–1.53; HR per 20 g/day higher intake of processed meat 1.18, 1.03–1.31] and red meat was associated with colon cancer risk (HR per 50 g/day higher intake of red meat 1.36, 1.13–1.64). Positive associations of red meat intake with colorectal and prostate cancer, processed meat intake with rectal cancer and poultry intake with cancers of the lymphatic and haematopoietic tissues did not survive multiple testing. Conclusions Higher intake of red and processed meat was specifically associated with a higher risk of colorectal cancer; there was little evidence that meat intake was associated with risk of other cancers.
first_indexed 2024-03-07T03:40:16Z
format Journal article
id oxford-uuid:bda4e2a6-3537-4b83-a01f-1259d3b0b10d
institution University of Oxford
language English
last_indexed 2024-03-07T03:40:16Z
publishDate 2020
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:bda4e2a6-3537-4b83-a01f-1259d3b0b10d2022-03-27T05:33:27ZMeat intake and cancer risk: prospective analyses in UK BiobankJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bda4e2a6-3537-4b83-a01f-1259d3b0b10dEnglishSymplectic ElementsOxford University Press2020Knuppel, APapier, KFensom, GAppleby, PSchmidt, JATong, YWrightson, RKey, TPerez-Cornago, ABackground Red and processed meat have been consistently associated with colorectal cancer risk, but evidence for other cancer sites and for poultry intake is limited. We therefore examined associations between total, red and processed meat and poultry intake and incidence for 20 common cancers. Methods We analyzed data from 474 996 participants (54% women) in UK Biobank. Participants were aged 37–73 years and cancer-free at baseline (2006–10). Multivariable-adjusted Cox proportional hazards models were used to determine associations between baseline meat intake and cancer incidence. Trends in risk across the baseline categories were calculated, assigning re-measured intakes from a subsample. Results During a mean follow-up of 6.9 years, 28 955 participants were diagnosed with malignant cancer. After correction for multiple testing, red and processed meat combined, and processed meat, were each positively associated with colorectal cancer risk [hazard ratio (HR) per 70 g/day higher intake of red and processed meat 1.32, 95% confidence interval 1.14–1.53; HR per 20 g/day higher intake of processed meat 1.18, 1.03–1.31] and red meat was associated with colon cancer risk (HR per 50 g/day higher intake of red meat 1.36, 1.13–1.64). Positive associations of red meat intake with colorectal and prostate cancer, processed meat intake with rectal cancer and poultry intake with cancers of the lymphatic and haematopoietic tissues did not survive multiple testing. Conclusions Higher intake of red and processed meat was specifically associated with a higher risk of colorectal cancer; there was little evidence that meat intake was associated with risk of other cancers.
spellingShingle Knuppel, A
Papier, K
Fensom, G
Appleby, P
Schmidt, JA
Tong, Y
Wrightson, R
Key, T
Perez-Cornago, A
Meat intake and cancer risk: prospective analyses in UK Biobank
title Meat intake and cancer risk: prospective analyses in UK Biobank
title_full Meat intake and cancer risk: prospective analyses in UK Biobank
title_fullStr Meat intake and cancer risk: prospective analyses in UK Biobank
title_full_unstemmed Meat intake and cancer risk: prospective analyses in UK Biobank
title_short Meat intake and cancer risk: prospective analyses in UK Biobank
title_sort meat intake and cancer risk prospective analyses in uk biobank
work_keys_str_mv AT knuppela meatintakeandcancerriskprospectiveanalysesinukbiobank
AT papierk meatintakeandcancerriskprospectiveanalysesinukbiobank
AT fensomg meatintakeandcancerriskprospectiveanalysesinukbiobank
AT applebyp meatintakeandcancerriskprospectiveanalysesinukbiobank
AT schmidtja meatintakeandcancerriskprospectiveanalysesinukbiobank
AT tongy meatintakeandcancerriskprospectiveanalysesinukbiobank
AT wrightsonr meatintakeandcancerriskprospectiveanalysesinukbiobank
AT keyt meatintakeandcancerriskprospectiveanalysesinukbiobank
AT perezcornagoa meatintakeandcancerriskprospectiveanalysesinukbiobank